Education
M.D. University of Pennsylvania
Ph.D. University of Pennsylvania
B.A. Harvard College
Publications
Defending Opioid Treatment Agreements: Disclosure, not Promises. (With Joshua Rager.) 2017. Hastings Center Report 47 (3): 24–33.
Progress in Defining Disease: Improved Approaches and Increased Impact. 2017. Journal of Medicine and Philosophy 42 (4): 485–502.
Comparative Risk: Good or Bad Heuristic? 2016. American Journal of Bioethics 16 (5): 20–22.
Placebos, Full Disclosure, and Trust: The Risks and Benefits of Disclosing Risks and Benefits. 2015. American Journal of Bioethics 15 (10): 13–14.
Patient Preferences in Controlling Access to their Electronic Health Records: A Prospective Cohort Study in Primary Care. (With Kelly Caine, Sheri A. Alpert, Eric M. Meslin, Aaron E. Carroll, and Williams M. Tierney.) 2015. Journal of General Internal Medicine 30: 25–30.
Provider Responses to Patients Controlling Access to their Electronic Health Record: A Prospective Cohort Study in Primary Care. (With William M. Tierney, Sheri A. Alpert, Amy Byrket, Kelly Caine, Jeremy C. Leventhal, and Eric M. Meslin.) 2015. Journal of General Internal Medicine 30 (1): 31–37.
Small Tumors as Risk Factors not Disease. 2014. Philosophy of Science 81 (5): 986–998.
How Bioethics Principles can Aid Design of Electronic Health Records to Accommodate Patient Granular Control. (With Eric M. Meslin.) 2014. Journal of General Internal Medicine 30 (1): 3–6.
Reframing the Disease Debate and Defending the Biostatistical Theory. 2014. Journal of Medicine and Philosophy 39 (6): 572–589.
Patient Understanding of Benefits, Risks, and Alternatives to Screening Colonoscopy. (With Elizabeth Edenberg, Patrick R Barrett, Susan M. Perkins, Eric M. Meslin, and Thomas F. Imperiale.) 2013. Family Medicine 45 (2): 83–89.
Older Adults and Forgoing Cancer Screening. (With Alexia M. Torke, Laura R. Holtz, Kianna Montz, and Greg A. Sachs.) 2013. Journal of the American Medical Association Internal Medicine 173 (7): 526–531.
Giving Patients Granular Control of Personal Health Information: Using an Ethics ‘Points to Consider’ to Inform Informatics System Designers. (With Eric M. Meslin, Sheri A. Alpert, Aaron E. Carroll, Jere D. Odell, and William M. Tierney.) 2013. International Journal of Medical Information 82: 1136–1143.
Discounting a Surgical Risk: Data, Understanding, and Gist. 2012. American Medical Association Journal of Ethics 14 (7): 532–538.
Child Safety, Absolute Risk, and the Prevention Paradox. 2012. Hastings Center Report 42 (4): 20–23.
Questioning the Quantitative Imperative: Decision Aids, Prevention, and the Ethics of Disclosure. 2011. Hastings Center Report 41 (2): 30–39.
To Be or Not to Be – A Research Subject. (With Eric M. Meslin.) 2010. In Thomasine Kushner (ed.), Surviving Health Care: A Manuel for Patients and their Families. Cambridge University Press. 146–162.
Autonomy and Consent in Biobanks. 2010. The Physiologist 53 (1): 1, 3–7.
The Value of Information and the Ethics of Personal-Genomic Screening. 2009. American Journal of Bioethics 9 (4): 26–27.
The Ethics of Information: Absolute Risk Reduction and Patient Understanding of Screening. (With Eric M. Meslin.) 2008. Journal of General Internal Medicine 23 (6): 867–870.
Stem Cells: Biopsy on Frozen Embryos. 2007. Hastings Center Report 37 (1): 7.
Disclosure and Rationality: Comparative Risk Information and Decision-Making about Prevention. 2009. Theoretical Medicine and Bioethics 30 (3): 199–213.
Risk and Disease. 2008. Perspectives in Biology and Medicine 51 (3): 320–334.
Decision and Discovery in Defining “Disease”. 2007. In Harold Kincaid & Jennifer McKitrick (eds.), Establishing Medical Reality: Essays in the Metaphysics and Epistemology of Biomedical Science. Springer. 47–63.
Silence about Screening. 2007. American Journal of Bioethics 7 (7): 46–48.
Is the Patient Always Right? (With Anne Drapkin Lyerly.) 2004. Hastings Center Report 34 (2): 13–14.
An Alternative to Conceptual Analysis in the Function Debate. 2004. The Monist87 (1): 136–153.
The Continuing Usefulness Account of Proper Function. 2002. In Andre Ariew, Robert Cummins, & Mark Perlman (eds.), Functions: New Essays in the Philosophy of Psychology and Biology. Clarendon Press.
Defining Dysfunction: Natural Selection, Design, and Drawing a Line. 2007. Philosophy of Science 74 (3): 364–385.
Defending the Distinction between Treatment and Enhancement. 2005. American Journal of Bioethics 5 (3): 17–19.
Proper Function and Recent Selection. 1999. Philosophy of Science 66 (3): 210–222.
Additional publications available at PhilPapers.
